Quantum BioPharma approved to dual list on Upstream

Quantum BioPharma announced its approval to dual list its shares on Upstream, a MERJ Exchange market and global securities trading app. Trading becomes available on Upstream Tuesday, January 14, 2025, at 10:00am ET under the ticker symbol ‘QNTM.’ The dual listing on Upstream is designed to provide Quantum the opportunity to access a global investor base outside of the U.S. that can trade using a credit/debit card, PayPal, USD, or USDC; unlocking liquidity and enhancing price discovery while globalizing the opportunity to invest in the company.